1. Home
  2. BCAB vs NSYS Comparison

BCAB vs NSYS Comparison

Compare BCAB & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • NSYS
  • Stock Information
  • Founded
  • BCAB 2007
  • NSYS 1981
  • Country
  • BCAB United States
  • NSYS United States
  • Employees
  • BCAB N/A
  • NSYS N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • NSYS Industrial Machinery/Components
  • Sector
  • BCAB Health Care
  • NSYS Technology
  • Exchange
  • BCAB Nasdaq
  • NSYS Nasdaq
  • Market Cap
  • BCAB 27.0M
  • NSYS 29.0M
  • IPO Year
  • BCAB 2020
  • NSYS N/A
  • Fundamental
  • Price
  • BCAB $0.31
  • NSYS $9.66
  • Analyst Decision
  • BCAB Buy
  • NSYS
  • Analyst Count
  • BCAB 2
  • NSYS 0
  • Target Price
  • BCAB $5.00
  • NSYS N/A
  • AVG Volume (30 Days)
  • BCAB 1.1M
  • NSYS 5.1K
  • Earning Date
  • BCAB 03-25-2025
  • NSYS 03-19-2025
  • Dividend Yield
  • BCAB N/A
  • NSYS N/A
  • EPS Growth
  • BCAB N/A
  • NSYS 109.80
  • EPS
  • BCAB N/A
  • NSYS 1.55
  • Revenue
  • BCAB $11,000,000.00
  • NSYS $135,567,000.00
  • Revenue This Year
  • BCAB N/A
  • NSYS N/A
  • Revenue Next Year
  • BCAB N/A
  • NSYS N/A
  • P/E Ratio
  • BCAB N/A
  • NSYS $6.34
  • Revenue Growth
  • BCAB N/A
  • NSYS N/A
  • 52 Week Low
  • BCAB $0.24
  • NSYS $9.53
  • 52 Week High
  • BCAB $4.02
  • NSYS $19.15
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 32.63
  • NSYS 39.98
  • Support Level
  • BCAB $0.24
  • NSYS $9.76
  • Resistance Level
  • BCAB $0.36
  • NSYS $10.25
  • Average True Range (ATR)
  • BCAB 0.04
  • NSYS 0.37
  • MACD
  • BCAB 0.01
  • NSYS -0.06
  • Stochastic Oscillator
  • BCAB 29.39
  • NSYS 0.00

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.

Share on Social Networks: